# Shinji Furuta
**Type:** Researchers
**Canonical URL:** https://scholariq.org/researchers/shinji-furuta/
## Facts
| Field | Value |
| --- | --- |
| Citations | 338 |
| Field | Dialysis and Renal Disease Management |
| h-index | 11 |
| i10-index | 12 |
| OpenAlex ID | https://openalex.org/A5102505177 |
| Works | 24 |
## Researcher papers
- [Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients](https://scholariq.org/papers/quality-of-life-and-emotional-distress-in-peritoneal-dialysis-and-hemodialysis/)
- [Pharmacokinetics and metabolism of \[14C\]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans](https://scholariq.org/papers/pharmacokinetics-and-metabolism-of-sup-14-sup-c-anagliptin-a-novel-dipeptidyl/)
- [The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice](https://scholariq.org/papers/the-alpha-glucosidase-inhibitor-miglitol-affects-bile-acid-metabolism-and/)
- [Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis](https://scholariq.org/papers/liraglutide-improves-glycemic-and-blood-pressure-control-and-ameliorates/)
- [Liraglutide relieves cardiac dilated function than DPP‐4 inhibitors](https://scholariq.org/papers/liraglutide-relieves-cardiac-dilated-function-than-scp-dpp-scp-4-inhibitors/)
- [Association between DNA Methylation in the miR-328 5’-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta](https://scholariq.org/papers/association-between-dna-methylation-in-the-mir-328-5-flanking-region-and-inter/)
- [Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport](https://scholariq.org/papers/dipeptidyl-peptidase-4-inhibitor-anagliptin-ameliorates-hypercholesterolemia-in/)
- [Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment](https://scholariq.org/papers/impact-of-glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose/)
- [A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics](https://scholariq.org/papers/a-pilot-study-examining-the-effects-of-tolvaptan-on-residual-renal-function-in/)
- [Long Term Effects of Liraglutide in Japanese Patients with type 2 Diabetes Among the Subgroups with Different Renal Functions: Results of 2-Year Prospective Study](https://scholariq.org/papers/long-term-effects-of-liraglutide-in-japanese-patients-with-type-2-diabetes-among/)
## Researcher topics
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.